This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Suzhou Transcenta Therapeutics Co., Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 159 
2 out of 100 
1 out of 1 Years Active: 2022-2026
Title: Xueming Qian: Innovator in Antibody Development
Introduction
Xueming Qian is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of antibody development. With a total of two patents to his name, he has made strides in medical applications that address critical health issues.
Latest Patents
Xueming Qian's latest patents include a human IL-4R binding antibody and an anti-CD40 antibody. The first patent focuses on a human IL-4R binding antibody, its antigen binding fragment, and its medical use. This innovation provides a chimeric antibody and a humanized antibody that includes a CDR region from a human IL-4R binding antibody. It also details a pharmaceutical composition that utilizes this antibody for treating allergic diseases. The second patent involves an anti-CD40 antibody, which also includes an antigen binding fragment and its medical applications. This patent highlights the potential of the humanized anti-CD40 antibody in developing drugs for treating CD40-mediated diseases or disorders.
Career Highlights
Throughout his career, Xueming Qian has worked with notable companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Xueming Qian has collaborated with esteemed colleagues, including Jiahua Jiang and Lianshan Zhang, to further enhance his research and innovations in the field of antibody therapies.
Conclusion
Xueming Qian's work in developing innovative antibodies showcases his commitment to advancing medical science. His patents reflect a dedication to addressing significant health challenges through targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile